Insulet Corporation Convertible Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Insulet Corporation of $800 million principal amount of 0.375% convertible senior notes due 2026,…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Davis Polk Advises BBVA on Its $1 Billion SEC-Registered Preferred Securities Offering
Davis Polk advised Banco Bilbao Vizcaya Argentaria, S.A. on its SEC-registered offering of $1 billion liquidation preference of series 9 non-step-up non-cumulative contingent convertible…
Davis Polk Advises Uniti on Its $345 Million Exchangeable Notes Offering and Related Hedge and Warrant Transactions
Davis Polk advised Uniti Group Inc. (“Uniti Group”) and Uniti Fiber Holdings Inc. (“Uniti Fiber,” and together with Uniti Group, “Uniti”) in connection with a Rule 144A offering of $345…
YY Inc. $1 Billion Convertible Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A and Regulation S offering by YY Inc. (NASDAQ: YY) of $425 million aggregate principal amount of 0.750% convertible…
Zynga $690 Million Convertible Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Zynga Inc. of $690 million aggregate principal amount of its 0.25% convertible senior notes due 2024,…
Coupa Software $805 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Coupa Software Incorporated of $805 million aggregate principal amount of its 0…
IAC $1.15 Billion Exchangeable Senior Notes Offerings and Related Exchangeable Note Hedge and Warrant Transactions
Davis Polk advised the initial purchasers in connection with Rule 144A offerings by IAC FinanceCo 2, Inc. and IAC FinanceCo 3, Inc., wholly owned subsidiaries of IAC/InterActiveCorp (“IAC”)…
Intercept Pharmaceuticals, Inc. Concurrent $231 Million Common Stock Offering and $230 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 2,760,000 shares of common stock of Intercept Pharmaceuticals, Inc. …
iQIYI, Inc. $1.2 Billion Convertible Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A and Regulation S offering by iQIYI, Inc. of $1.2 billion aggregate principal amount of its 2.00% convertible senior…
Chegg, Inc. $700 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Chegg, Inc. of $700 million aggregate principal amount of its 0.125% convertible…